SYBX Synlogic
- 1.7900
- -0.0400-2.19%
Synlogic News
Form 144 | Synlogic(SYBX.US) Insider Proposes to Sell 161.58K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 22, $Synlogic(SYBX.US)$ Insider Brennan Aoife intends to sell 88,293 shares of its common stock on Apr 19, with a total market value of approximately $161.58K. Brennan Ao
Synlogic(SYBX.US) Officer Sells US$325.24 in Common Stock
$Synlogic(SYBX.US)$ Officer Dooley Mary Beth sold 188 shares of Common Stock on Apr 2, 2024 at an average price of $1.73 for a total value of $325.24.Source: Announcement What is statement of changes
Synlogic(SYBX.US) Officer Sells US$643.56 in Common Stock
$Synlogic(SYBX.US)$ Officer Awad Antoine sold 372 shares of Common Stock on Apr 2, 2024 at an average price of $1.73 for a total value of $643.56.Source: Announcement What is statement of changes in b
Synlogic Appoints James Flynn to Board Amidst Director Resignations
Hold Rating on Synlogic Amidst Lead Program Discontinuation and Strategic Uncertainties
Synlogic Raised to Neutral From Sell by HC Wainwright & Co.
Synlogic Raised to Neutral From Sell by HC Wainwright & Co.
Synlogic Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/20/2024 — HC Wainwright & Co. Upgrades Sell → Neutral 02/09/2024 — Chardan Capital Downgrades Buy → N
H.C. Wainwright Upgrades Synlogic (SYBX) to a Hold
Synlogic Q4 EPS $(1.71) Misses $(0.97) Estimate, Sales $2.77M Beat $2.73M Estimate
Synlogic (NASDAQ:SYBX) reported quarterly losses of $(1.71) per share which missed the analyst consensus estimate of $(0.97) by 76.29 percent. This is a 52.5 percent increase over losses of $(3.60) pe
Synlogic 4Q Rev $2.77M >SYBX
Synlogic 4Q Rev $2.77M >SYBX
Press Release: Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results
Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results CAMBRIDGE, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel th
Synlogic Announces Top Executive Departures and Compensation Deals
Synlogic Enacts Shareholder Rights Plan for Equitable Control
Synlogic Board Approves Poison Pill Defense After Unsolicited Accumulation of Shares
Synlogic (SYBX) said Tuesday its board approved a limited duration shareholder rights plan, also known as a poison pill defense, in response to an unsolicited accumulation of Synlogic stock by an unna
Synlogic Adopts Limited Duration Stockholders Rights Plan
Engages Ladenburg Thalmann as financial advisor to assist with previously announced strategic review processCAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a bioph
Hold Rating on Synlogic Amid Discontinued Lead Program and Reduced Price Target
Synlogic Announces Major Restructuring and Leadership Changes
U.S. Shares Mixed at Close of Trade; Dow Jones Industrial Average Down 0.14%
Sector Update: Health Care
Health care stocks were mixed late Friday afternoon with the NYSE Health Care Index adding 0.3% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.1%. The iShares Biotechnology ETF (IBB) ros
Why Synlogic (SYBX) Stock Is Down Nearly 50% Today
Synlogic Inc (NASDAQ:SYBX) shares are trading lower by 48.4% to $1.78 Friday afternoon after the company announced it will discontinue Synpheny-3, cease operations and reduce its workforce by more tha
Analysis
Price Target
No Data
